Iran is a leading country in the region in production of biotech drugs, said Mostafa Qanei, secretary of the Biotechnology Development Headquarters, on Monday.
There are currently 146 biotech medicines in the world, of which 20 drugs are produced domestically and are available in the Iranian market, Mehr News Agency reported.
“Biotech drugs available in Iran include four monoclonal antibodies and 16 recombinant drugs,” he explained.
According to him, 61 drugs are on Iran’s national priority list, of which 29 are in various phases of clinical trials of production in knowledge-based companies.
“It is estimated that the new drugs will enter the Iranian market by 2020,” he added.
Add new comment
Read our comment policy before posting your viewpoints